All resources

Paediatricians sub-specialising in child mental health promote mental wellbeing and work with children and families with mental health difficulties. Read about this clinical area and download the syllabi for both sub-specialty and for generic specialty training. We also have an educational super...

Doctors specialising in community child health (CCH) work with vulnerable groups of children, including those with developmental disorders and disabilities, complex behavioural presentations, and at risk of abuse or are being abused. Read about this clinical area and download the syllabi for both...

This policy outlines how the College complies with UK Data Protection legislation.

Our NICE accredited evidence-based clinical guideline (published 2015) provides recommendations on the diagnosis of death by neurological criteria (DNC) in infants from 37 weeks corrected gestation (post menstrual) to two months of age (post term). It is for all UK paediatric and neonatal health car...

A general paediatrician is a doctor with the knowledge and skills to manage a wide range of health problems and concerns in children and young people. Read about this clinical area and download the syllabi for specialty training level (general paediatrics and generic).

The RCPCH has annual income in excess of £15m per year with expenditure of a similar size. The College reserves and cash balances have increased in recent years. This policy sets out how these balances can be invested.

Decreased conscious level can be considered an acute neurological emergency. It is characterised by significant brain impairment, which needs a rapid and methodical approach to evaluation and treatment. Our NICE accredited 2015 evidence-based clinical guideline provides practitioners working acu...

Published in December 2023, this clinical practice guideline developed by RCPCH and the Neonatal and Paediatric Pharmacy Group Joint Standing Committee on Medicines (RCPCH-NPPG), covers the inclusion of medication analysis in the paediatric ward round environment to improve medication safety.

This guidance covers the pathway and clinical considerations in the following situations: (1) care of a child or young person (CYP) with suspected Mpox, (2) CYP contact of a confirmed case of Mpox, (3) newborn baby of a mother with suspected or confirmed Mpox. This page was updated...